The introduction of the Oculan Lighting Platform by Stryker is likely to positively impact the company's stock in the short term. This new product enhances surgical visualization and illumination, which is critical in operating rooms. As a leader in medical technologies, Stryker's innovation could lead to increased adoption of their products, potentially boosting revenues and investor confidence.